Literature DB >> 24743961

Suicidal erythrocyte death in end-stage renal disease.

Majed Abed1, Ferruh Artunc, Kousi Alzoubi, Sabina Honisch, Dorothea Baumann, Michael Föller, Florian Lang.   

Abstract

UNLABELLED: Anemia in end-stage renal disease (ESRD) results mainly from erythropoietin and iron deficiency. Anemia could be confounded, however, by accelerated clearance of circulating erythrocytes because of premature suicidal erythrocyte death or eryptosis characterized by phosphatidylserine exposure at the erythrocyte surface. Triggers of eryptosis include increased cytosolic Ca(2+) concentration ([Ca(2+)]i), oxidative stress, and ceramide. The present study explored whether and how ESRD influences eryptosis. Blood was drawn from healthy volunteers (n = 20) as well as ESRD patients (n = 20) prior to and after hemodialysis. Phosphatidylserine exposure was estimated from annexin V binding, [Ca(2+)]i from Fluo3-fluorescence, reactive oxygen species (ROS) from 2',7'dichlorodihydrofluorescein fluorescence, and ceramide from fluorescein-isothiocyanate-conjugated antibody binding in flow cytometry. Measurements were made in erythrocytes from freshly drawn blood and in erythrocytes from healthy volunteers exposed in vitro for 24 h to plasma from healthy volunteers or ESRD patients prior to and following dialysis. The patients suffered from anemia (hemoglobin 10.1 ± 0.5 g/100 ml) despite 1.96 ± 0.34 % reticulocytes. The percentage of phosphatidylserine-exposing erythrocytes was significantly higher in ESRD patients (0.84 ± 0.09 %) than in healthy volunteers (0.43 ± 0.04 %) and was significantly increased immediately after dialysis (1.35 ± 0.13 %). The increase in phosphatidylserine exposure was paralleled by increase in [Ca(2+)]i, oxidative stress, and ceramide abundance. As compared to addition of plasma from healthy individuals, addition of predialytic but not of postdialytic plasma from ESRD patients increased phosphatidylserine exposure, [Ca(2+)]i, ROS, and ceramide abundance. In conclusion, both, dialyzable components of uremic plasma and dialysis procedure, trigger eryptosis at least in part by increasing erythrocyte [Ca(2+)]i, ROS, and ceramide formation. KEY MESSAGES: Anemia in uremia results in part from eryptosis, the suicidal erythrocyte death. Eryptosis in uremia is triggered in part by a dialyzable plasma component. Eryptosis in uremia is further triggered by dialysis procedure. Eryptosis in uremia is in part due to increased cytosolic Ca(2+) concentration. Eryptosis in uremia is further due to oxidative stress and ceramide formation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743961     DOI: 10.1007/s00109-014-1151-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  40 in total

Review 1.  Complications of progression of CKD.

Authors:  Min Yang; Chester H Fox; Joseph Vassalotti; Michael Choi
Journal:  Adv Chronic Kidney Dis       Date:  2011-11       Impact factor: 3.620

2.  Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure.

Authors:  Patrick S Parfrey
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

3.  Age sensitivity of NFκB abundance and programmed cell death in erythrocytes induced by NFκB inhibitors.

Authors:  Mehrdad Ghashghaeinia; Judith C Cluitmans; Mahmoud Toulany; Mohammad Saki; Martin Köberle; Elisabeth Lang; Peter Dreischer; Tilo Biedermann; Michael Duszenko; Florian Lang; Giel J Bosman; Thomas Wieder
Journal:  Cell Physiol Biochem       Date:  2013-09-20

Review 4.  Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.

Authors:  Suetonia C Palmer; Sankar D Navaneethan; Jonathan C Craig; David W Johnson; Marcello Tonelli; Amit X Garg; Fabio Pellegrini; Pietro Ravani; Meg Jardine; Vlado Perkovic; Giusi Graziano; Richard McGee; Antonio Nicolucci; Gianni Tognoni; Giovanni F M Strippoli
Journal:  Ann Intern Med       Date:  2010-06-24       Impact factor: 25.391

5.  Sunitinib-sensitive suicidal erythrocyte death.

Authors:  Nazneen Shaik; Adrian Lupescu; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2012-07-19

Review 6.  What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?

Authors:  Anatole Besarab; Stanley Frinak; Jerry Yee
Journal:  Adv Chronic Kidney Dis       Date:  2009-03       Impact factor: 3.620

Review 7.  Hyporesponsiveness to erythropoietin: causes and management.

Authors:  James Elliott; Dennis Mishler; Rajiv Agarwal
Journal:  Adv Chronic Kidney Dis       Date:  2009-03       Impact factor: 3.620

Review 8.  Hemoglobin variability and hyporesponsiveness: much ado about something or nothing?

Authors:  Jerry Yee; Gerard Zasuwa; Stanley Frinak; Anatole Besarab
Journal:  Adv Chronic Kidney Dis       Date:  2009-03       Impact factor: 3.620

9.  Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations.

Authors:  Jakob Voelkl; Kousi Alzoubi; Abdel-Karim Mamar; Mohamed Siyabeldin E Ahmed; Majed Abed; Florian Lang
Journal:  Kidney Blood Press Res       Date:  2014-02-10       Impact factor: 2.687

10.  Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.

Authors:  Ferruh Artunc; Teut Risler
Journal:  Nephrol Dial Transplant       Date:  2007-06-07       Impact factor: 5.992

View more
  17 in total

1.  Cytotoxicity of anti-tumor herbal Marsdeniae tenacissimae extract on erythrocytes.

Authors:  Ke Hao; Bing-Yu Chen; Kai-Qiang Li; Yu Zhang; Cai-Xia Li; Ying Wang; Lu-Xi Jiang; Jiang Shen; Xiang-Chai Guo; Wei Zhang; Meng-Hua Zhu; Zhen Wang
Journal:  J Zhejiang Univ Sci B       Date:  2017-07       Impact factor: 3.066

2.  Olive Oil Phenols Prevent Mercury-Induced Phosphatidylserine Exposure and Morphological Changes in Human Erythrocytes Regardless of Their Different Scavenging Activity.

Authors:  Rosaria Notariale; Pasquale Perrone; Luigi Mele; Gennaro Lettieri; Marina Piscopo; Caterina Manna
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

3.  Blockage of the Na-K-ATPase signaling-mediated oxidant amplification loop elongates red blood cell half-life and ameliorates uremic anemia induced by 5/6th PNx in C57BL/6 mice.

Authors:  Jiang Liu; Muhammad Chaudhry; Fang Bai; Justin Chuang; Hibba Chaudhry; Ala-Eddin Yassin Al-Astal; Ying Nie; Vincent Sollars; Komal Sodhi; Paul Seligman; Joseph I Shapiro
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-18

4.  Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients.

Authors:  Natalia Di Pietro; Annalisa Giardinelli; Vittorio Sirolli; Chiara Riganti; Pamela Di Tomo; Elena Gazzano; Sara Di Silvestre; Christina Panknin; Miriam M Cortese-Krott; Csaba Csonka; Malte Kelm; Péter Ferdinandy; Mario Bonomini; Assunta Pandolfi
Journal:  Mol Cell Biochem       Date:  2016-05-20       Impact factor: 3.396

5.  Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.

Authors:  Matthew B Rivara; T Alp Ikizler; Charles D Ellis; Rajnish Mehrotra; Jonathan Himmelfarb
Journal:  BMC Nephrol       Date:  2015-06-05       Impact factor: 2.388

Review 6.  Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.

Authors:  Elisabeth Lang; Florian Lang
Journal:  Biomed Res Int       Date:  2015-03-04       Impact factor: 3.411

7.  Triggering of Erythrocyte Death by Triparanol.

Authors:  Arbace Officioso; Caterina Manna; Kousi Alzoubi; Florian Lang
Journal:  Toxins (Basel)       Date:  2015-08-24       Impact factor: 4.546

8.  Eryptosis Indices as a Novel Predictive Parameter for Biocompatibility of Fe3O4 Magnetic Nanoparticles on Erythrocytes.

Authors:  Qian Ran; Yang Xiang; Yao Liu; Lixin Xiang; Fengjie Li; Xiaojun Deng; Yanni Xiao; Li Chen; Lili Chen; Zhongjun Li
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

9.  Blunted apoptosis of erythrocytes in mice deficient in the heterotrimeric G-protein subunit Gαi2.

Authors:  Rosi Bissinger; Elisabeth Lang; Mehrdad Ghashghaeinia; Yogesh Singh; Christine Zelenak; Birgit Fehrenbacher; Sabina Honisch; Hong Chen; Hajar Fakhri; Anja T Umbach; Guilai Liu; Rexhep Rexhepaj; Guoxing Liu; Martin Schaller; Andreas F Mack; Adrian Lupescu; Lutz Birnbaumer; Florian Lang; Syed M Qadri
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

10.  A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.

Authors:  Asadur Rahman; Daisuke Yamazaki; Abu Sufiun; Kento Kitada; Hirofumi Hitomi; Daisuke Nakano; Akira Nishiyama
Journal:  PLoS One       Date:  2018-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.